Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular Dys ...

Fidelity Value Factor ETF (FVAL) has a 0.15% expense ratio. It outperforms its peers, but faces higher risk. Read an ...

As US navigates a shifting landscape of trade policy under new administration, markets grappling with implications of ...

TC Energy Corporation (TC Energy or the Company) released its fourth quarter results today. François Poirier, TC Energy's President and Chief Executive Officer commented, "Our strategic priorities ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...